Kalaris Therapeutics KLRS Delivers Q1 2026 Beat EPS 046 vs 053 Expected Why NVIDIA Corporation NVDA Just Dropped 351 What to Watch 20260515 Jim Cramer Endorses Restaurant Brands QSR as Leading FastFood Player Northern NTIC Steady at 790 Awaiting Next Catalyst 20260519 Short Sellers Target Fake AI Stocks Amid Tech Mania CNBC Reports Replimune Group REPL Gains 892 Support Holds at 510 20260515 JT Ginns Near NoHitter What the FourPitch Collapse Means for His Market Value and the Angels Playoff Push